Evaluation of the CRISPR/Cas9 system as genome editing platform for the Mucopolysaccharidosis IV A using a strategy for induction of higher homologous recombination frequency. (2025). Universitas Scientiarum, 30, 82-106. https://doi.org/10.11144/